Invention Grant
US07772232B2 Quinazolinyl compounds as inhibitors of potassium channel function
有权
喹唑啉基化合物作为钾通道功能的抑制剂
- Patent Title: Quinazolinyl compounds as inhibitors of potassium channel function
- Patent Title (中): 喹唑啉基化合物作为钾通道功能的抑制剂
-
Application No.: US11104856Application Date: 2005-04-13
-
Publication No.: US07772232B2Publication Date: 2010-08-10
- Inventor: James A. Johnson , John Lloyd
- Applicant: James A. Johnson , John Lloyd
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Terence J. Bogie
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61K31/517 ; A61K31/433 ; A61K31/42 ; A61K31/416 ; A61K31/4172 ; A61K31/5355 ; C07D231/56 ; C07D261/20 ; A61P29/00 ; A61P19/02 ; A61P3/10 ; C07D235/04 ; C07D277/62 ; C07D498/00 ; C07D209/82 ; C07D215/12 ; C07D215/14 ; C07D215/20 ; C07D215/36 ; C07D215/38
Abstract:
A compound of formula I wherein m, n, A, B, D, E, G, H, Y, R1, R2, R3, R4, R5, and R8, are described herein. Said compounds being useful as inhibitors of potassium channel function and in the treatment of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Public/Granted literature
- US20050250783A1 Fused heterocyclic compounds Public/Granted day:2005-11-10
Information query
IPC分类:
